Literature DB >> 8216336

Biosynthesis and processing of the platelet derived growth factor type alpha receptor.

B E Bejcek1, N Voravud, T F Deuel.   

Abstract

The homodimers (AA, BB) of the platelet derived growth factor (PDGF) differentially interact with two highly related PDGF receptors (alpha, beta) that appear to mediate different functional responses in different cell types. To seek a basis for these apparent functional differences, we investigated the processing of the PDGF alpha-receptor. The PDGF alpha-receptor is rapidly glycosylated to a 160 kD form and undergoes a number of intermediate glycosylation steps that result in a mature form of 185 kD that appears at the cell surface within 60-90 minutes. The alpha receptor has a half-life of approximately 4 1/2 hours without and approximately 20 minutes in the presence of ligand. The processing steps of the alpha-receptor are similar to the processing of the PDGF beta receptor, suggesting that differential binding of signalling molecules to activated receptors may be responsible for the apparent functional differences in cellular responses to PDGF AA and PDGF BB.

Mesh:

Substances:

Year:  1993        PMID: 8216336     DOI: 10.1006/bbrc.1993.2217

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts.

Authors:  H R Kim; S Upadhyay; G Li; K C Palmer; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

2.  Platelet-derived growth factor-mediated signal transduction underlying astrocyte proliferation: site of ethanol action.

Authors:  J Luo; M W Miller
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

3.  Molecular kinetics of nerve growth factor receptor trafficking and activation.

Authors:  Jérôme Jullien; Vincent Guili; Louis F Reichardt; Brian B Rudkin
Journal:  J Biol Chem       Date:  2002-06-07       Impact factor: 5.157

4.  Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies.

Authors:  Carman K M Ip; Patrick K S Ng; Kang Jin Jeong; S H Shao; Zhenlin Ju; P G Leonard; Xu Hua; Christopher P Vellano; Richard Woessner; Nidhi Sahni; Kenneth L Scott; Gordon B Mills
Journal:  Nat Commun       Date:  2018-11-02       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.